LMX4® is indicated for "Topical anaesthesia of intact skin prior
to superficial skin procedures including IV cannulation and
blood sampling
>> read more
LMX4® can help alleviate pain and discomfort associated with cosmetic treatments.
>> read more
LMX4® is a safe and effective anaesthetic cream1 2 .LMX4® can be used prior to tattooing to allleviate pain and discomfort.
>> read more
LMX4® has been used by millions of patients in the USA and is now available in Australia. LMX4® is available from pharmacies without a prescription and is used by healthcare professionals prior to medical procedures.
Always read the label.
1) Taddio et al, CMAJ 2005; 172(13): 1691–95.
2) Koh et al, Pediatric Anesthesia 2004; 14: 977–98.
3) LMX4® Summary of Product Characteristics, TGA August 2011.
4) Nestor, Journal of Drugs in Dermatology 2006, 5(7): 618–20.
5) Mezei M in Hsieh DS, ed. Drug permeation enhancement. New York, NY: Marcel Dekker Inc; 1994:171–98.
6) Kleiber et al, Pediatrics 2002; 100(4).
7) Emla Product Information March 2010.
8) Local AnGel RCH Melbourne, Consumer Health Information, 22 November 2002.
EMLA® is a registered trademark of AstraZeneca.
Distributed in Australia and New Zealand by Dermocosmètica ABN 52152881019.
88 Mount Alexander Rd, Flemington VIC 3031 Australia | P.O. Box. 285, Batman VIC 3058
Telephone: +61 (0)3 9386 3503
Fax: +61 (0)3 8692 6923
Email: lmx4@dermocosmetica.com.au
Copyright © Dermocosèmtica 2013. All rights reserved.
No part of this publication may be stored in a
retrieval system or reproduced by any means whatsoever without the written consent of the publisher.
